39To comply with paragraph 38, an insurer shall disclose:

39 To comply with paragraph 38, an insurer shall disclose:
(a) its objectives, policies and processes for managing risks arising from insurance contracts and the methods used to manage those risks.
(b) \[deleted\]
(c) information about insurance risk (both before and after risk mitigation by reinsurance), including information about:
(i) sensitivity to insurance risk (see paragraph 39A).
(ii) concentrations of insurance risk, including a description of how management determines concentrations and a description of the shared characteristic that identifies each concentration (eg type of insured event, geographical area, or currency).
(iii) actual claims compared with previous estimates (ie claims development). The disclosure about claims development shall go back to the period when the earliest material claim arose for which there is still uncertainty about the amount and timing of the claims payments, but need not go back more than ten years. An insurer need not disclose this information for claims for which uncertainty about the amount and timing of claims payments is typically resolved within one year.
(d) information about credit risk, liquidity risk and market risk that paragraphs 31–42 of AASB 7 would require if the insurance contracts were within the scope of AASB 7. However:
(i) an insurer need not provide the maturity analyses required by paragraph 39(a) and (b) of AASB 7 if it discloses information about the estimated timing of the net cash outflows resulting from recognised insurance liabilities instead. This may take the form of an analysis, by estimated timing, of the amounts recognised in the statement of financial position.
(ii) if an insurer uses an alternative method to manage sensitivity to market conditions, such as an embedded value analysis, it may use that sensitivity analysis to meet the requirement in paragraph 40(a) of AASB 7. Such an insurer shall also provide the disclosures required by paragraph 41 of AASB 7.
(e) information about exposures to market risk arising from embedded derivatives contained in a host insurance contract if the insurer is not required to, and does not, measure the embedded derivatives at fair value.